Kitasato PCI Registry

Kitasato Percutaneous Coronary Intervention Registry

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05308329

Enrollment

4500

Registered

2022-04-04

Start date

2012-02-01

Completion date

2025-03-31

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Atherosclerosis, Coronary; Ischemic, NSTEMI - Non-ST-Segment Elevation Myocardial Infarction, Stable Angina, STEMI - ST-segment Elevation Myocardial Infarction

Brief summary

The Kitasato PCI Registry is a single-center, observational, prospective study. This study aims to investigate the impact of characteristics in clinical manifestation, patients' background, procedure of percutaneous coronary intervention (PCI), and pre/post PCI culprit/nonculprit lesion observed by intra-coronary imaging modality on clinical outcomes.

Detailed description

Subjects who underwent PCI are eligible in this registry. The analysis for clinical characteristics, PCI procedural characteristics and findings of intra-coronary imaging including optical coherence tomography (OCT) and intravascular ultrasound (IVUS) is conducted. Subjects are clinically followed up to 5 years after the PCI.

Interventions

DEVICEIntra-coronary imaging device

Culprit/nonculprit lesions are accessed by intra-coronary imaging device including intravascular ultrasound and optical coherence tomography.

BEHAVIORALPCI procedural characteristics

Procedural characteristics include the information about angiographical characteristics, type of stent, pre/post POBA, and thrombectomy.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients who underwent PCI

Exclusion criteria

* Patients who did not agree to participate in the registry

Design outcomes

Primary

Measure	Time frame	Description
Device-oriented clinical end points (DoCE)	5 years after the PCI	Composite of all-cause death, myocardial infarction, ischemic stroke, clinically indicated Composite of cardiac death, target lesion revascularization and stent thrombosis

Secondary

Measure	Time frame	Description
Major adverse cardiac and cerebrovascular events (MACCE)	5 years after the PCI	Composite of all-cause death, myocardial infarction, ischemic stroke, clinically indicated coronary revascularization

Countries

Japan

Contacts

Primary ContactYoshiyasu Minami

nrg12391@yahoo.co.jp

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026